Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 36, 1976 - Issue 4
Submit an article Journal homepage
53
Views
127
CrossRef citations to date
0
Altmetric
Original

Progression of Nephropathy in Long-Term Diabetics with Proteinuria and Effect of Initial Anti-Hypertensive Treatment

C. E. Mogensen Second University Clinic of Internal Medicine, Kommunehospitalet, Århus, Denmark
Pages 383-388 | Received 30 Dec 1975, Accepted 11 May 1976, Published online: 14 Feb 2011

Citations (127)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Samuel S. Blumenthal. (2011) Evolution of Treatment for Diabetic Nephropathy: Historical Progression from RAAS Inhibition and Onward. Postgraduate Medicine 123:6, pages 166-179.
Read now
Sanjib Kumar Sharma, Piero Ruggenenti & Giuseppe Remuzzi. (2007) Managing hypertension in diabetic patients – focus on trandolapril/verapamil combination. Vascular Health and Risk Management 3:4, pages 453-465.
Read now
Norberto Perico, Piero Ruggenenti & Giuseppe Remuzzi. (2004) Losartan in diabetic nephropathy. Expert Review of Cardiovascular Therapy 2:4, pages 473-483.
Read now
Garry P Reams. (1996) Section Review; Cardiovascular & Renal: Calcium channel blockers for the treatment of renal disease. Expert Opinion on Investigational Drugs 5:5, pages 521-534.
Read now
Thomas P. Dunfee. (1995) The Changing Management of Diabetic Nephropathy. Hospital Practice 30:5, pages 45-55.
Read now
Maryella D. Sirmonw & Wanda G. Kirkpatrick. (1991) Diabetic Nephropathy: New Directions in Management. Renal Failure 13:2-3, pages 51-59.
Read now
H. Tindall, S. Urquhart, M. Stickland & J. A. Davies. (1991) Treatment with atenolol prevents progression of microalbuminuria in Type I diabetic patients. Current Medical Research and Opinion 12:8, pages 516-520.
Read now
C. K. Christensen & C. E. Mogensen. (1986) Acute and long-term effect of antihypertensive treatment on exercise-induced albuminuria in incipient diabetic nephropathy. Scandinavian Journal of Clinical and Laboratory Investigation 46:6, pages 553-559.
Read now

Articles from other publishers (119)

Masayuki Yamanouchi, Naoki Sawa, Tadashi Toyama, Miho Shimizu, Megumi Oshima, Yusuke Yoshimura, Hisashi Sugimoto, Shigekazu Kurihara, Yuki Oba, Daisuke Ikuma, Hiroki Mizuno, Akinari Sekine, Tatsuya Suwabe, Junichi Hoshino, Yoshifumi Ubara, Shigeko Hara, Kengo Furuichi & Takashi Wada. (2024) Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease. Kidney International Reports 9:2, pages 323-333.
Crossref
Chu-Hsuan Shiau, Li-Yun Tsau, Chih-Chin Kao, Yu-Ching Peng, Chyi-Huey Bai, Jeng‑Cheng Wu & Wen-Hsuan Hou. (2023) Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients with chronic kidney disease: a systematic review and meta-analysis. International Urology and Nephrology 56:4, pages 1359-1381.
Crossref
Stefanos Roumeliotis, Francesca Mallamaci & Carmine Zoccali. 2023. Blood Pressure Disorders in Diabetes Mellitus. Blood Pressure Disorders in Diabetes Mellitus 243 269 .
Allison B. Dart. 2023. Pediatric Kidney Disease. Pediatric Kidney Disease 865 876 .
V.I. Katerenchuk. (2021) The effect of modern hypoglycemic therapy on the course of chronic kidney disease in patients with type 2 diabetes mellitus. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 17:8, pages 624-632.
Crossref
Désirée Tampe, Peter Korsten, Philipp Ströbel, Samy Hakroush & Björn Tampe. (2021) Proteinuria Indicates Decreased Normal Glomeruli in ANCA-Associated Glomerulonephritis Independent of Systemic Disease Activity. Journal of Clinical Medicine 10:7, pages 1538.
Crossref
Dorte Vistisen, Gregers Stig Andersen, Adam Hulman, Frederik Persson, Peter Rossing & Marit Eika Jørgensen. (2019) Progressive Decline in Estimated Glomerular Filtration Rate in Patients With Diabetes After Moderate Loss in Kidney Function—Even Without Albuminuria. Diabetes Care 42:10, pages 1886-1894.
Crossref
Misghina Weldegiorgis, Dick de Zeeuw, Liang Li, Hans-Henrik Parving, Fan Fan Hou, Giuseppe Remuzzi, Tom Greene & Hiddo J.L. Heerspink. (2018) Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy. American Journal of Kidney Diseases 71:1, pages 91-101.
Crossref
Richard B. Stacey, Veronica D'Ambra & Petro Gjini. 2018. Lifestyle in Heart Health and Disease. Lifestyle in Heart Health and Disease 267 274 .
Andrzej S. Krolewski, Jan Skupien, Peter Rossing & James H. Warram. (2017) Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes. Kidney International 91:6, pages 1300-1311.
Crossref
Jan Skupien, James H. Warram, Adam M. Smiles, Robert C. Stanton & Andrzej S. Krolewski. (2016) Patterns of Estimated Glomerular Filtration Rate Decline Leading to End-Stage Renal Disease in Type 1 Diabetes. Diabetes Care 39:12, pages 2262-2269.
Crossref
Matthew D. Breyer & Katalin Susztak. (2016) The next generation of therapeutics for chronic kidney disease. Nature Reviews Drug Discovery 15:8, pages 568-588.
Crossref
Meena Bhatia, Harendra Arora & Priya A. Kumar. (2016) Pro: ACE Inhibitors Should Be Continued Perioperatively and Prior to Cardiovascular Operations. Journal of Cardiothoracic and Vascular Anesthesia 30:3, pages 816-819.
Crossref
Maria Luiza Avancini Caramori & Peter Rossing. 2016. Endocrinology: Adult and Pediatric. Endocrinology: Adult and Pediatric 934 957.e12 .
Bernadette Thomas, Sarah Wulf, Boris Bikbov, Norberto Perico, Monica Cortinovis, Karen Courville de Vaccaro, Abraham Flaxman, Hannah Peterson, Allyne Delossantos, Diana Haring, Rajnish Mehrotra, Jonathan Himmelfarb, Giuseppe Remuzzi, Christopher Murray & Mohsen Naghavi. (2015) Maintenance Dialysis throughout the World in Years 1990 and 2010. Journal of the American Society of Nephrology 26:11, pages 2621-2633.
Crossref
Ian H. de Boer, Maryam Afkarian, Tessa C. Rue, Patricia A. Cleary, John M. Lachin, Mark E. Molitch, Michael W. Steffes, Wanjie Sun & Bernard Zinman. (2014) Renal Outcomes in Patients with Type 1 Diabetes and Macroalbuminuria. Journal of the American Society of Nephrology 25:10, pages 2342-2350.
Crossref
Marilia B. Gomes, Lucianne Righeti Monteiro Tannus, Alessandra Saldanha de Mattos Matheus, Roberta Arnoldi Cobas, Catia C. Sousa Palma, Aline Tiemi Kano Silva, Carlos Antonio Negrato, Sergio Atala Dib, Melanie Rodacki, João Soares Felício & Luis Henrique Canani. (2013) Prevalence, Awareness, and Treatment of Hypertension in Patients with Type 1 Diabetes: A Nationwide Multicenter Study in Brazil. International Journal of Hypertension 2013, pages 1-8.
Crossref
Jicheng Lv, Vlado Perkovic, Celine V Foote, Maria E Craig, Jonathan C Craig & Giovanni FM Strippoli. (2012) Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews.
Crossref
Aurelie Miot, Stéphanie Ragot, Wala Hammi, Pierre-Jean Saulnier, Philippe Sosner, Xavier Piguel, Florence Torremocha, Richard Marechaud & Samy Hadjadj. (2012) Prognostic Value of Resting Heart Rate on Cardiovascular and Renal Outcomes in Type 2 Diabetic Patients. Diabetes Care 35:10, pages 2069-2075.
Crossref
Jan Skupien, James H. Warram, Adam M. Smiles, Monika A. Niewczas, Tomohito Gohda, Marcus G. Pezzolesi, Diego Cantarovich, Robert Stanton & Andrzej S. Krolewski. (2012) The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease. Kidney International 82:5, pages 589-597.
Crossref
Heather N. Reich, David Tritchler, Daniel C. Cattran, Andrew M. Herzenberg, Felix Eichinger, Anissa Boucherot, Anna Henger, Celine C. Berthier, Viji Nair, Clemens D. Cohen, James W. Scholey & Matthias Kretzler. (2010) A Molecular Signature of Proteinuria in Glomerulonephritis. PLoS ONE 5:10, pages e13451.
Crossref
Maria Luiza Avancini Caramori, Peter Rossing & Michael Mauer. 2010. Endocrinology. Endocrinology 999 1030 .
K. Khavandi, A. S. Greenstein, K. Sonoyama, S. Withers, A. Price, R. A. Malik & A. M. Heagerty. (2008) Myogenic tone and small artery remodelling: insight into diabetic nephropathy. Nephrology Dialysis Transplantation 24:2, pages 361-369.
Crossref
Eun-Gyoung Hong. (2008) Clinical Significance of Decreased Glomerular Filtration Rate (GFR) without Albuminuria among Type 2 Diabetics (Korean Diabetes Journal 32(3):252-258, 2008). Korean Diabetes Journal 32:4, pages 386.
Crossref
Eun Gyoung Hong. (2008) Diabetic Nephropathy - Preventive effects of lithospermic acid B (LAB). Korean Diabetes Journal 32:1, pages 7.
Crossref
Marcin Adamczak & Eberhard Ritz. 2008. Seldin and Giebisch's The Kidney. Seldin and Giebisch's The Kidney 2537 2561 .
MARK B. LANDON. (2007) Diabetic Nephropathy and Pregnancy. Clinical Obstetrics & Gynecology 50:4, pages 998-1006.
Crossref
Lynn M Robertson, Norman Waugh & Aileen Robertson. (2007) Protein restriction for diabetic renal disease. Cochrane Database of Systematic Reviews 2009:1.
Crossref
Sudha K. Iyengar, Hanna E. Abboud, Katrina A.B. Goddard, Mohammed F. Saad, Sharon G. Adler, Nedal H. Arar, Donald W. Bowden, Ravi Duggirala, Robert C. Elston, Robert L. Hanson, Eli Ipp, W.H. Linda Kao, Paul L. Kimmel, Michael J. Klag, William C. Knowler, Lucy A. Meoni, Robert G. Nelson, Susanne B. Nicholas, Madeleine V. Pahl, Rulan S. Parekh, Shannon R.E. Quade, Stephen S. Rich, Jerome I. Rotter, Marina Scavini, Jeffrey R. Schelling, John R. Sedor, Ashwini R. Sehgal, Vallabh O. Shah, Michael W. Smith, Kent D. Taylor, Cheryl A. Winkler, Philip G. Zager & Barry I. Freedman. (2007) Genome-Wide Scans for Diabetic Nephropathy and Albuminuria in Multiethnic Populations. Diabetes 56:6, pages 1577-1585.
Crossref
Jorge Luiz Gross, Sandra Pinho Silveiro, Luís Henrique Canani, Rogério Friedman, Cristiane Bauermann Leitão & Mirela Jobim de Azevedo. (2007) Nefropatia diabética e doença cardíaca. Arquivos Brasileiros de Endocrinologia & Metabologia 51:2, pages 244-256.
Crossref
P. Rossing. (2005) Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005. Diabetologia 49:1, pages 11-19.
Crossref
Ticiana C. Rodrigues, Miriam Pecis, Mirela J. Azevedo & Jorge L. Gross. (2005) Homeostase pressórica e complicações microvasculares em pacientes diabéticos. Arquivos Brasileiros de Endocrinologia & Metabologia 49:6, pages 882-890.
Crossref
K. Rossing, P. K. Christensen, P. Hovind & H.-H. Parving. (2005) Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients. Diabetologia 48:11, pages 2241-2247.
Crossref
David M. Maahs, Gregory L. Kinney, Paul Wadwa, Janet K. Snell-Bergeon, Dana Dabelea, John Hokanson, James Ehrlich, Satish Garg, Robert H. Eckel & Marian J. Rewers. (2005) Hypertension Prevalence, Awareness, Treatment, and Control in an Adult Type 1 Diabetes Population and a Comparable General Population. Diabetes Care 28:2, pages 301-306.
Crossref
Jorge L. Gross, Mirela J. de Azevedo, Sandra P. Silveiro, Luís Henrique Canani, Maria Luiza Caramori & Themis Zelmanovitz. (2005) Diabetic Nephropathy: Diagnosis, Prevention, and Treatment. Diabetes Care 28:1, pages 164-176.
Crossref
DE Huw Llewelyn & Juan Garcia-Puig. (2016) How different urinary albumin excretion rates can predict progression to nephropathy and the effect of treatment in hypertensive diabetics. Journal of the Renin-Angiotensin-Aldosterone System 5:3, pages 141-145.
Crossref
Peter Hovind, Lise Tarnow, Peter Rossing, Bendix Carstensen & Hans-Henrik Parving. (2004) Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy. Kidney International 66:3, pages 1180-1186.
Crossref
Peter Hovind, Lise Tarnow & Hans-Henrik Parving. (2004) Remission and regression of diabetic nephropathy. Current Hypertension Reports 6:5, pages 377-382.
Crossref
Anthony L. McCall. (2004) Hypertension management in patients with diabetic nephropathy. Current Hypertension Reports 6:4, pages 272-279.
Crossref
Jonathan D Rippin, Anthony H Barnett & Stephen C Bain. (2004) Cost-Effective Strategies in the Prevention of Diabetic Nephropathy. PharmacoEconomics 22:1, pages 9-28.
Crossref
David M. Ward. 2004. Educating, Evaluating, and Selecting Living Kidney Donors. Educating, Evaluating, and Selecting Living Kidney Donors 99 128 .
Steen Andersen, Lise Tarnow, Francois Cambien, Peter Rossing, Tina R. Juhl, Jaap Deinum & Hans-Henrik Parving. (2003) Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy. Diabetes Care 26:5, pages 1501-1506.
Crossref
GFM Strippoli, M Craig, FP Schena & JC Craig. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Peter Hovind, Peter Rossing, Lise Tarnow & Hans-Henrik Parving. (2003) Smoking and Progression of Diabetic Nephropathy in Type 1 Diabetes. Diabetes Care 26:3, pages 911-916.
Crossref
Løgstrup Poulsen. (2016) Blood pressure and cardiac autonomic function in relation to risk factors and treatment perspectives in Type 1 diabetes. Journal of the Renin-Angiotensin-Aldosterone System 3:4, pages 222-242.
Crossref
Christopher A. Newton & Philip Raskin. (2002) Blood pressure control—Effects on diabetic nephropathy progression: How low does blood pressure have to be?. Current Diabetes Reports 2:6, pages 530-538.
Crossref
Pascale H. Lane. (2002) Diabetic kidney disease: impact of puberty. American Journal of Physiology-Renal Physiology 283:4, pages F589-F600.
Crossref
Henrik P. Hansen, Ellis Tauber-Lassen, Berit R. Jensen & Hans-Henrik Parving. (2002) Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney International 62:1, pages 220-228.
Crossref
MARY H. BRANTON, RAPHAEL SCHIFFMANN, SHARDA G. SABNIS, GARY J. MURRAY, JANE M. QUIRK, GHEONA ALTARESCU, LEV GOLDFARB, ROSCOE O. BRADY, JAMES E. BALOW, HOWARD A. AUSTINIIIIII & JEFFREY B. KOPP. (2002) Natural History of Fabry Renal Disease. Medicine 81:2, pages 122-138.
Crossref
Taisuke Okada, Yasuko Uchigata, Hiroki Yokoyama, Takashi Tomoda & Yasuhiko Iwamoto. (2002) Risk Factors for Diabetic Complications in Juvenile-Onset Type 1 Diabetic Patients. Clinical Pediatric Endocrinology 11:1, pages 55-65.
Crossref
Radko Komers & Sharon Anderson. (2001) Treatment of hypertension in diabetic patients with nephropathy. Current Diabetes Reports 1:3, pages 251-260.
Crossref
Peter Hovind, Peter Rossing, Lise Tarnow, Henrik Toft, Jeppe Parving & Hans-Henrik Parving. (2001) Remission of Nephrotic-Range Albuminuria in Type 1 Diabetic Patients. Diabetes Care 24:11, pages 1972-1977.
Crossref
Peter Hovind, Peter Rossing, Lise Tarnow, Ulla M. Smidt & Hans-Henrik Parving. (2001) Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively11See Editorial by Steffes, p. 378. Kidney International 60:1, pages 277-283.
Crossref
Maarten W. Taal, Glenn M. Chertow, Helmut G. Rennke, Anuradha Gurnani, Tang Jiang, Aliakbar Shahsafaei, Julia L. Troy, Barry M. Brenner & Harald S. Mackenzie. (2001) Mechanisms underlying renoprotection during renin-angiotensin system blockade. American Journal of Physiology-Renal Physiology 280:2, pages F343-F355.
Crossref
Peter Hovind, Peter Rossing, Lise Tarnow, Ulla M. Smidt & Hans-Henrik Parving. (2001) Progression of diabetic nephropathy. Kidney International 59:2, pages 702-709.
Crossref
Alluru S. ReddiVenkata R. NimmagaddaAza LefkowitzHon-Reen KuoJaya S. Bollineni. (2000) Effect of Antihypertensive Therapy on Renal Injury in Type 2 Diabetic Rats With Hypertension. Hypertension 36:2, pages 233-238.
Crossref
Maarten W. Taal & Barry M. Brenner. (2000) Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists. Kidney International 57:5, pages 1803-1817.
Crossref
Peter Hovind, Lise Tarnow, Per B. Oestergaard & Hans-Henrik Parving. (2000) Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy. Kidney International 57, pages S56-S61.
Crossref
Peter Jacobsen, Kasper Rossing, Lise Tarnow, Peter Rossing, Christine Mallet, Odette Poirier, Francois Cambien & Hans-Henrik Parving. (1999) Progression of diabetic nephropathy in normotensive type 1 diabetic patients. Kidney International 56, pages S101-S105.
Crossref
P. K. Christensen, P. Rossing, F. S. Nielsen & H. ‐H. Parving. (2001) Natural course of kidney function in Type 2 diabetic patients with diabetic nephropathy. Diabetic Medicine 16:5, pages 388-394.
Crossref
Philip S. Mehler & Robert W. Schrier. (1999) Antihypertensive drugs and diabetic nephropathy. Current Hypertension Reports 1:2, pages 170-177.
Crossref
Jennifer B. Marks & Philip Raskin. (1998) NEPHROPATHY AND HYPERTENSION IN DIABETES. Medical Clinics of North America 82:4, pages 877-907.
Crossref
Robert TotoPamela ShultzLeopoldo RaijHelen MitchellWayne ShawDenise RamjitJenny TohShahnaz Shahinfar. (1998) Efficacy and Tolerability of Losartan in Hypertensive Patients With Renal Impairment. Hypertension 31:2, pages 684-691.
Crossref
Manuel T. VelasquezJohn S. StrifflerAndrew A. AbrahamOtho E. MichaelisIVIVElizabeth ScalbertNancy Thibault. (1997) Perindopril Ameliorates Glomerular and Renal Tubulointerstitial Injury in the SHR/N-Corpulent Rat. Hypertension 30:5, pages 1232-1237.
Crossref
NR Waugh & AM Robertson. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Garikiparthy N. JyothirmayiIndira AlluruAlluru S. Reddi. (1996) Doxazosin Prevents Proteinuria and Glomerular Loss of Heparan Sulfate in Diabetic Rats. Hypertension 27:5, pages 1108-1114.
Crossref
Gregory S. Raskin & William V. Tamborlane. (1996) Molecular and physiological aspects of nephropathy in type I (insulin-dependent) diabetes mellitus. Journal of Diabetes and its Complications 10:1, pages 31-37.
Crossref
Andrea Manto, Patrizia Cotroneo, Giampiero Marra, Paolo Magnani, Pietro Tilli, Aldo V. Greco & Giovanni Ghirlanda. (1995) Effect of intensive treatment on diabetic nephropathy in patients with type I diabetes. Kidney International 47:1, pages 231-235.
Crossref
L. D. Elving, J. F. M. Wetzels, H. J. J. van Lier, E. de Nobel & J. H. M. Berden. (1994) Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Diabetologia 37:6, pages 604-609.
Crossref
P. Rossing, E. Hommel, U. M. Smidt & H. -H. Parving. (1994) Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologia 37:5, pages 511-516.
Crossref
Carlos Arauz-Pacheco & Philip Raskin. (1992) Management of Hypertension in Diabetes. Endocrinology and Metabolism Clinics of North America 21:2, pages 371-394.
Crossref
M EpsteinJ R Sowers. (1992) Diabetes mellitus and hypertension.. Hypertension 19:5, pages 403-418.
Crossref
L FerderH DaccordiM MartelloM PanzalisF Inserra. (1992) Angiotensin converting enzyme inhibitors versus calcium antagonists in the treatment of diabetic hypertensive patients.. Hypertension 19:2_supplement.
Crossref
C. E. Mogensen, E. M. Damsgaard, A. Fr�land, K. W. Hansen, S. Nielsen, M. Mau Pedersen, A. Schmitz, L. Thuesen & R. �sterby. (1992) Reduced glomerular filtration rate and cardiovascular damage in diabetes: a key role for abnormal albuminuria. Acta Diabetologica 29:3-4, pages 201-213.
Crossref
Anthony Fazio. (2016) Failure of Captopril Therapy for Diabetic Proteinuria. Journal of Pharmacy Technology 7:2, pages 56-58.
Crossref
David S.H. Bell. (1991) Diabetic Nephropathy: Changing Concepts of Pathogenesis and Treatment. The American Journal of the Medical Sciences 301:3, pages 195-200.
Crossref
Gian Carlo Viberti. (1990) Mechanisms of diabetic renal and cardiovascular disease. Acta Diabetologica Latina 27:3, pages 267-276.
Crossref
R. G. Bretzel. 1990. Blutdrucksenkung heute — Korrektur von Struktur und Funktion der Arterie. Blutdrucksenkung heute — Korrektur von Struktur und Funktion der Arterie 61 86 .
G. Pugliese, R. G. Tilton, A. Speedy, K. Chang, E. Santarelli, M. A. Province, D. Eades, W. R. Sherman & J. R. Williamson. (1989) Effects of very mild versus overt diabetes on vascular haemodynamics and barrier function in rats. Diabetologia 32:12, pages 845-857.
Crossref
Stuart W Zarich & Richard W Nesto. (1989) Diabetic cardiomyopathy. American Heart Journal 118:5, pages 1000-1012.
Crossref
Gwendolyn B. Graybar & Mark H. Deierhoi. (1989) Anesthesia and Pancreatic Transplantation. Anesthesiology Clinics of North America 7:3, pages 515-549.
Crossref
D M Gibb, D Dunger, M Levin, V Shah, C Smith & T M Barratt. (1989) Early markers of the renal complications of insulin dependent diabetes mellitus.. Archives of Disease in Childhood 64:7, pages 984-991.
Crossref
Manuel Tzagournis. (1989) Interaction of diabetes with hypertension and lipids—patients at high risk. The American Journal of Medicine 86:1, pages 50-54.
Crossref
Jean L. Olson & Robert H. Heptinstall. 1990. Pathology Reviews · 1989. Pathology Reviews · 1989 155 169 .
R. W. Schrier & H. Holzgreve. (1988) Hemodynamic factors in the pathogenesis of diabetic nephropathy. Klinische Wochenschrift 66:8, pages 325-331.
Crossref
Sebastiano Bruno Solerte, Marisa Fioravanti, Anna Linda Patti, Nicola Schifino, Maria Grazia Zanoletti, Valeria Inglese & Ettore Ferrari. (1987) Pentoxifylline, total urinary protein excretion rate and arterial blood pressure in long-term insulin-dependent diabetic patients with overt nephropathy. Acta Diabetologica Latina 24:3, pages 229-239.
Crossref
Norman Bank, Ruth Klose, Hagop S. Aynedjian, Dang Nguyen & Leonarda B. Sablay. (1987) Evidence against increased glomerular pressure initiating diabetic nephropathy. Kidney International 31:4, pages 898-905.
Crossref
C.K. Christensen & C.E. Mogensen. (1987) Antihypertensive treatment: Long-term reversal of progression of albuminuria in incipient diabetic nephropathy. A longitudinal study of renal function. Journal of Diabetic Complications 1:2, pages 45-52.
Crossref
C.E. Mogensen. (1987) Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney International 31:2, pages 673-689.
Crossref
A. Grenfell. (1986) Diabetic nephropathy: Historical aspects. Clinics in Endocrinology and Metabolism 15:4, pages 727-731.
Crossref
E Hommel, H H Parving, E Mathiesen, B Edsberg, M Damkjaer Nielsen & J Giese. (1986) Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.. BMJ 293:6545, pages 467-470.
Crossref
J J Bending, G C Viberti, P J Watkins & H Keen. (1986) Intermittent clinical proteinuria and renal function in diabetes: evolution and the effect of glycaemic control.. BMJ 292:6513, pages 83-86.
Crossref
C Hasslacher, E Ritz, J Terpstra, G Gallasch, G Kunowski & C Rall. (1985) Natural history of nephropathy in type I diabetes. Relationship to metabolic control and blood pressure.. Hypertension 7:6_pt_2.
Crossref
C E Mogensen & C K Christensen. (1985) Blood pressure changes and renal function in incipient and overt diabetic nephropathy.. Hypertension 7:6_pt_2.
Crossref
K Thygesen, M Strate, L Hansen & B Harvald. (1985) Survival of diabetic hypertensive patients.. Hypertension 7:6_pt_2.
Crossref
H H Parving, A R Andersen, E Hommel & U Smidt. (1985) Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy.. Hypertension 7:6_pt_2.
Crossref
C K Christensen & C E Mogensen. (1985) Effect of antihypertensive treatment on progression of incipient diabetic nephropathy.. Hypertension 7:6_pt_2.
Crossref
Frederick S. Fein & Edmund H. Sonnenblick. (1985) Diabetic cardiomyopathy. Progress in Cardiovascular Diseases 27:4, pages 255-270.
Crossref
Ch. Hasslacher, W. Stech, P. Wahl & E. Ritz. (1985) Blood pressure and metabolic control as risk factors for nephropathy in Type 1 (insulin-dependent) diabetes. Diabetologia 28:1, pages 6-11.
Crossref
C. E. MogensenC. K. Christensen. (1984) Predicting Diabetic Nephropathy in Insulin-Dependent Patients. New England Journal of Medicine 311:2, pages 89-93.
Crossref
Bernardo Léo Wajchenberg, Emil Sabbaga & João Américo Fonseca. (1984) The natural history of diabetic nephropathy in type I diabetes and the role of metabolic control in its prevention, reversibility and clinical course. Acta Diabetologica Latina 21:1, pages 1-18.
Crossref
JONAS BERGLUND, LARS-ERIC LINS & PER-ERIC LINS. (2009) Predictability in Diabetic Nephropathy. Acta Medica Scandinavica 215:3, pages 263-270.
Crossref
Silvio Bertoli, Riccardo Bottelli, Roberto Confalonieri, Loredana Radaelli, Carlo Rovati, Giovanni Barbiano Belgiojoso & Giorgio Micoli. (1983) Diabetic nephropathy: Clinical and histological study in 22 patients. Acta Diabetologica Latina 20:2, pages 125-133.
Crossref
G C Viberti, R W Bilous, D Mackintosh, J J Bending & H Keen. (1983) Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes. BMJ 286:6365, pages 598-602.
Crossref
G.C. Viberti, R.W. Bilous, D. Mackintosh & H. Keen. (1983) Monitoring glomerular function in diabetic nephropathy. The American Journal of Medicine 74:2, pages 256-264.
Crossref
Bernardo Léo Wajchenberg, Emil Sabbaga & Joào Américo Fonseca. (1983) The natural history of diabetic nephropathy in type I diabetes and the role of metabolic control in its prevention, reversibility and clinical course. Acta Diabetologica Latina 20:1, pages 1-18.
Crossref
Stephen M. Factor, Takashi Minase, Raj Bhan, Harvey Wolinsky & Edmund H. Sonnenblick. (1983) Hypertensive diabetic cardiomyopathy in the rat: ultrastructural features. Virchows Archiv A Pathological Anatomy and Histopathology 398:3, pages 305-317.
Crossref
C E Mogensen. (1982) Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ 285:6343, pages 685-688.
Crossref
Jan A. Winetz, Helen V. Golbetz, Robin J. Spencer, Jeri A. Lee & Bryan D. Myers. (1982) Glomerular function in advanced human diabetic nephropathy. Kidney International 21:5, pages 750-756.
Crossref
Shang Der Shieh, Sondra R. Hirsch, Burris R. Boshell, Jorge A. Pino, Larry J. Alexander, David M. Witten & Eli A. Friedman. (1982) Low risk of contrast media-induced acute renal failure in nonazotemic type 2 diabetes mellitus. Kidney International 21:5, pages 739-743.
Crossref
Jean Fabre, Luc P. Balant, Pierre G. Dayer, Hilke M. Fox & André T. Vernet. (1982) The kidney in maturity onset diabetes mellitus: A clinical study of 510 patients. Kidney International 21:5, pages 730-738.
Crossref
GianCarlo Viberti, David Mackintosh, Rudolf W. Bilous, John C. Pickup & Harry Keen. (1982) Proteinuria in diabetes mellitus: Role of spontaneous and experimental variation of glycemia. Kidney International 21:5, pages 714-720.
Crossref
Bryan D. Myers, Jan A. Winetz, Francis Chui & Alan S. Michaels. (1982) Mechanisms of proteinuria in diabetic nephropathy: A study of glomerular barrier function. Kidney International 21:4, pages 633-641.
Crossref
John L. Kitzmiller, Elizabeth R. Brown, Mark Phillippe, Ann R. Stark, David Acker, Antoine Kaldany, Shilini Singh & John W. Hare. (1981) Diabetic nephropathy and perinatal outcome. American Journal of Obstetrics and Gynecology 141:7, pages 741-751.
Crossref
. (1981) Prolonged disease-free survival in diabetics.. BMJ 282:6273, pages 1339-1340.
Crossref
S.Michael Mauer, Michael W. Steffes & David M. Brown. (1981) The kidney in diabetes. The American Journal of Medicine 70:3, pages 603-612.
Crossref
Brian J. Carrie, Bryan D. Myers & with the technical assistance of Helen Golbetz. (1980) Proteinuria and functional characteristics of the glomerular barrier in diabetic nephropathy. Kidney International 17:5, pages 669-676.
Crossref
J. B. Ferriss, P. A. Sullivan, H. Gonggrijp, A. A. Long & D. J. O’Sullivan. (1979) Hypertension, hyperkalaemia and abnormalities of the renin-angiotensin system in diabetes mellitus. Irish Journal of Medical Science 148:S2, pages 17-27.
Crossref
C. E. Mogensen, R. �sterby & H. J. G. Gundersen. (1979) Early functional and morphologic vascular renal consequences of the diabetic state. Diabetologia 17:2, pages 71-76.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.